Filtros

Buscador
Año
Plasencia-Martinez JM, Oton-Gonzalez E, Sanchez-Canales M, Ortiz-Mayoral H, Cotillo-Ramos E, Casado-Alarcon NI, Ballesta-Ruiz M, Villaverde-Gonzalez R, Garcia-Santos JM. Clinical prediction scale approach derived from a retrospective study to reduce the number of urgent, low-value cranial CT scans. Emerg Radiol. 2024 Dec;31(6):835-843. doi: 10.1007/s10140-024-02274-6. Epub 2024 Jul 26. PubMed PMID: 39060810.
AÑO: 2024
Fonseca E., Olivé-Cirera G., Martinez-Hernandez E., Guasp M., Naranjo L., Ruiz-García R., Caballero E., González-Álvarez V., Delgadillo V., Romeu G., del-Prado-Sánchez C., Cabrera-Maqueda J.M., Benito-León J., Iñiguez C., Garcia-Dominguez J.M., Calles C., Cano A., Álvarez-Bravo G., González-Suárez I., Oreja-Guevara C., Ros M., Millan-Pascual J., Meca-Lallana J.E., Borrega Canelo L., Martín-Martínez J., Palao M., Gracia J., Villaverde-González R., Llufriu S., Blanco Y., Saiz A., Dalmau J., Sepulveda M., Armangue T. Investigating the 2023 MOGAD Criteria in Children and Adults With MOG-Antibody Positivity Within and Outside Attacks. Neurology. 27 August 2024. 103. 10.1212/WNL.0000000000209682
AÑO: 2024; IF: 7.7
Aparicio-Castro E., Candeliere-Merlicco A., Santa C.M., Villaverde-González R. Usefulness of the Beck depression inventory in the diagnosis of depressive disorders in multiple sclerosis. Revista de Neurologia. 2024. 78:317-322. 10.33588/rn.7811.2024092
AÑO: 2024; IF: 0.8
Candeliere-Merlicco A, Villaverde-Gonzalez R, Hidalgo-Perez PV, Escobar-Arias FH, Aparicio-Castro E, Lastres-Arias MC. Dimethyl fumarate induced Wells syndrome. A case report. Rev Neurol. 2023 May 16;76(10):337-339. doi: 10.33588/rn.7610.2022323. English, Spanish. PubMed PMID: 37165530; PubMed Central PMCID: PMC10478104.
AÑO: 2023; IF: 0.8
Meca-Lallana JE, Prieto Gonzalez JM, Caminero Rodriguez AB, Olascoaga Urtaza J, Alonso AM, Duran Ferreras E, Espinosa R, Dotor J, Romera M, Ares Luque A, Perez Ruiz D, Calles C, Hernandez MA, Hervas Garcia M, Mendoza Rodriguez A, Berdei Montero Y, Tellez N, Herrera Varo N, Sotoca J, Presas-Rodriguez S, Querol Gutierrez LA, Hervas Pujol M, Batlle Nadal J, Martin Ozaeta G, Gubieras Lillo L, Martinez Yelamos S, Ramio-Torrenta L, Mallada Frechin J, Belenguer Benavides A, Gascon-Gimenez F, Casanova B, Landete Pascual L, Berenguer L, Navarro L, Gomez Gutierrez M, Duran C, Rodriguez Regal A, Alvarez E, Garcia-Estevez DA, Lopez Real AM, Llaneza Gonzalez MA, Marzo Sola ME, Sanchez-Menoyo JL, Oterino A, Villaverde Gonzalez R, Castillo-Trivino T, Alvarez de Arcaya A, Llarena C. Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study. Neurol Ther. 2023 Dec;12(6):2177-2193. doi: 10.1007/s40120-023-00557-7. Epub 2023 Oct 20. PubMed PMID: 37861931; PubMed Central PMCID: PMC10630277.
AÑO: 2023; IF: 3.9